Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind, 3-Arm Parallel Design Study to Investigate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Cleminorexton Compared With Placebo in Participants With Central Disorders of Hypersomnolence

NCT07598708 is registered in ClinicalTrials.gov with Centessa Pharmaceuticals (UK) Limited as lead sponsor.

NCT NCT07598708
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07598708 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind, 3-Arm Parallel Design Study to Investigate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Cleminorexton Compared With Placebo in Participants With Central Disorders of Hypersomnolence
Lead sponsor
Centessa Pharmaceuticals (UK) Limited
Phase
Phase 2/3
Overall status
Recruiting
Start date
May 29, 2026
Completion date
December 31, 2027
Enrollment
222 (estimated)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

narcolepsy type 1, narcolepsy type 2